Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03281356 · ClinicalTrials.gov registry record · NA

Text Messaging Pilot Study

A NA study of Literacy, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT03281356: Completed NA study of Literacy, sponsored by Rutgers, The State University of New Jersey.

NCT03281356 is a NA study of Literacy that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 16 participants, below the 124-participant average among 12 other Literacy trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03281356, a NA study of Literacy, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This pilot study aims to assess the acceptability, feasibility, and preliminary effectiveness of text messages designed to encourage shared reading among urban parents. We hypothesize that parents will report reading more often to their children after receiving the text messages.

Primary Outcome

Three questions on the participants feedback on the program.

Conditions Studied

Interventions

  • BEHAVIORAL Intervention Group

Study Locations (1)

New Jersey

  • Rutgers Robert Wood Johnson Medical School - New Brunswick

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2017-05-09
Est. Completion 2017-06-13
Phase NA

What the finished NCT03281356 record still lists

NCT03281356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 124-participant average among 12 other Literacy trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Literacy appearing as the primary indexed condition, and to 1 intervention - of which Intervention Group is the first listed.

NCT03281356 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT03281356 about?

NCT03281356 is a clinical study titled "Text Messaging Pilot Study". This pilot study aims to assess the acceptability, feasibility, and preliminary effectiveness of text messages designed to encourage shared reading among urban parents. We hypothesize that parents will report reading more often to their children after receiving the text messages.

What is the current status of trial NCT03281356?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-05-09. Estimated completion is 2017-06-13.

What conditions does trial NCT03281356 study?

This clinical trial studies the following conditions: Literacy.

What interventions are being tested in trial NCT03281356?

The interventions under investigation include: Intervention Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT03281356?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03281356 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Literacy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03281356's enrollment target sits among peer trials

16 13th of 12 the lowest of 12 other Literacy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Literacy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03281356, the US trial registry maintained by the National Library of Medicine. NCT03281356 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.